Effector Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Effector Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Effector Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Effector Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Effector Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $4.2k | 9.1k | 0.47 |
2023-09-30 | $5.9k | 9.9k | 0.60 |
2023-03-31 | $7.6k | 21k | 0.35 |
2022-12-31 | $11k | 26k | 0.43 |
2022-09-30 | $9.0k | 17k | 0.54 |
2022-03-31 | $1.0k | 141 | 7.09 |
2021-12-31 | $20k | 2.4k | 8.33 |